Nutritional Adequacy of a FODMAP Diet in Children
- Conditions
- Functional Gastrointestinal Disorders in Children
- Interventions
- Other: FODMAP's diet
- Registration Number
- NCT02117180
- Lead Sponsor
- Dr Anne Payne
- Brief Summary
This pilot study aims to establish whether a low FODMAP diet is safe in children with functional gastrointestinal disorders. The practicality of implementing this diet will be evaluated as well as symptom improvement and quality of life. A larger intervention trial, if deemed appropriate, will then follow to assess symptom efficacy in children.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 15
- Patients aged 10-16 years
- Informed consent and assent obtained
- Patients with diagnosed FGID according to Rome III criteria: i.e. category H2b (irritable bowel syndrome) and H2d (childhood functional abdominal pain)
- Patients with other gastrointestinal conditions (e.g. coeliac disease, inflammatory bowel disease)
- Patients with food allergies
- Patients with a weight for age below -2 Standard Deviations (SD) (below 0.4th centile) on the UK WHO growth charts.
- Patients with known micronutrient deficiencies determined by blood levels prior to study
- Patients without informed consent and assent obtained
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description FODMAP's diet FODMAP's diet A diet low in Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols (FODMAPs)
- Primary Outcome Measures
Name Time Method Energy and nutrient intake Baseline, 6 weeks Energy and nutrient intake will be assessed using a 4-day estimated food diary at baseline and 6-weeks after dietary intervention. Comparison will be made between baseline and 6-week data and with United Kingdom (UK) Reference Nutrient Intakes.
- Secondary Outcome Measures
Name Time Method Anthropometry: weight and mid-arm circumference Baseline, 6 weeks Anthropometric measurements will be taken at baseline and 6 weeks after dietary intervention. Comparison will be made between baseline and 6-week data for weight and mid upper arm circumference, as well as comparing both baseline and 6-week data to the UK-WHO growth standards.
Practicality of the FODMAP diet; impact of diet on Functional Gastro-Intestinal .Disorders (FGID) symptoms and stools Baseline, 6 weeks Practicality of the FODMAP diet will be evaluated using a standardised structured questionnaire.
The impact of a low FODMAP diet on FGID symptoms and stools will be assessed using a validated symptom questionnaire and the Bristol Stool Chart.
The impact of a low FODMAP diet on quality of life will be assessed using the Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Module.
Trial Locations
- Locations (1)
Chelsea and Westminster NHS Foundation Trust
🇬🇧London, United Kingdom